Chai Discovery, the company engineering AI models to discover new molecules, announces a license agreement with Pfizer.

Chai Discovery, a company that uses AI to predict and reprogram interactions between biochemical molecules, has secured $70 million in a Series A funding in a round led by Menlo Ventures, with an ...

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Chai Discovery, a company that builds frontier artificial intelligence models to predict and reprogram interactions between biochemical molecules, today announced it has raised $70 million to continue ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Agreement--Chai’s second with Lilly--enables biotechs in early biologics discovery to evaluate Chai’s miniprotein design suite Chai Discovery, the AI company engineering models to discover new ...

Chai Discovery’s AI platform, including purpose-built custom models, will be deployed to accelerate the discovery of next-generation therapeutics SAN FRANCISCO, January 09, 2026--(BUSINESS WIRE)--Chai ...

Chai Discovery has just vaulted into the biotech big leagues, securing a $130 million Series B round that values the company at $1.3 billion and signals how aggressively artificial intelligence is ...

San Francisco start-up Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B that will be used to build its computer-aided design (CAD) ...

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...